Condor Capital Management Boosts Stock Position in Crescent Capital BDC, Inc. $CCAP

Condor Capital Management grew its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 4.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,738 shares of the company’s stock after purchasing an additional 14,449 shares during the period. Condor Capital Management’s holdings in Crescent Capital BDC were worth $4,339,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Catalyst Capital Advisors LLC purchased a new stake in shares of Crescent Capital BDC during the second quarter valued at $69,000. Catalina Capital Group LLC bought a new stake in Crescent Capital BDC during the 2nd quarter valued at about $174,000. Barnett & Company Inc. purchased a new stake in Crescent Capital BDC in the 1st quarter valued at about $296,000. Ieq Capital LLC grew its stake in Crescent Capital BDC by 3.5% in the 1st quarter. Ieq Capital LLC now owns 23,518 shares of the company’s stock worth $403,000 after acquiring an additional 793 shares in the last quarter. Finally, Almitas Capital LLC bought a new position in Crescent Capital BDC in the 1st quarter worth about $414,000. 49.46% of the stock is currently owned by institutional investors.

Insider Transactions at Crescent Capital BDC

In other news, Director Raymond Barrios bought 3,245 shares of Crescent Capital BDC stock in a transaction on Monday, August 25th. The stock was acquired at an average cost of $15.63 per share, for a total transaction of $50,719.35. Following the completion of the acquisition, the director owned 19,177 shares of the company’s stock, valued at $299,736.51. This trade represents a 20.37% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by company insiders.

Analysts Set New Price Targets

CCAP has been the subject of a number of research reports. Wall Street Zen lowered Crescent Capital BDC from a “hold” rating to a “sell” rating in a report on Saturday. Zacks Research lowered Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research report on Wednesday, October 15th. Wells Fargo & Company lowered their target price on Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating for the company in a report on Friday. Keefe, Bruyette & Woods dropped their price target on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating on the stock in a research report on Friday. Finally, Oppenheimer cut their price target on Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating on the stock in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $16.38.

Crescent Capital BDC Stock Performance

Shares of NASDAQ:CCAP opened at $13.66 on Friday. The firm has a 50 day moving average of $14.51 and a 200 day moving average of $14.84. The company has a quick ratio of 1.27, a current ratio of 1.20 and a debt-to-equity ratio of 1.23. The company has a market capitalization of $505.28 million, a price-to-earnings ratio of 13.94 and a beta of 0.57. Crescent Capital BDC, Inc. has a 52 week low of $13.30 and a 52 week high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, November 12th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.01). Crescent Capital BDC had a net margin of 20.84% and a return on equity of 9.76%. The company had revenue of $41.35 million for the quarter, compared to the consensus estimate of $42.35 million. On average, sell-side analysts predict that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be paid a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 12.3%. The ex-dividend date is Wednesday, December 31st. Crescent Capital BDC’s payout ratio is 140.00%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.